Computerized analysis of the distribution of occlusal contacts in individuals with Parkinson's disease and temporomandibular disorder

CRANIO® ◽  
2016 ◽  
Vol 34 (6) ◽  
pp. 358-362 ◽  
Author(s):  
Paula Fernanda da Costa Silva ◽  
Lara Jansiski Motta ◽  
Soraia Micaela Silva ◽  
Raquel Agnelli Mesquita Ferrari ◽  
Kristianne Porta Santos Fernandes ◽  
...  
CRANIO® ◽  
2015 ◽  
pp. 2151090315Y.000 ◽  
Author(s):  
Paula Fernanda da Costa Silva ◽  
Lara Jansiski Motta ◽  
Soraia Micaela Silva ◽  
Raquel Agnelli Mesquita Ferrari ◽  
Kristianne Porta Santos Fernandes ◽  
...  

Revista CEFAC ◽  
2021 ◽  
Vol 23 (2) ◽  
Author(s):  
Jonatas Silva de Oliveira ◽  
Amanda do Vale Sobral ◽  
Taysa Vannoska de Almeida Silva ◽  
Maria das Graças Wanderley de Sales Coriolano ◽  
Carla Cabral dos Santos Accioly Lins

ABSTRACT Purpose: to analyze the predictors of temporomandibular disorder in people with Parkinson’s disease, verifying their associations with sociodemographic aspects and stages of the disease. Methods: a study based on secondary data from research conducted in 2017 with 110 people with Parkinson’s disease. They were assessed with the Research Diagnostic Criteria for Temporomandibular Disorders and the Parkinson’s disease staging scale. The studied predictive variables for temporomandibular disorder were pain, crepitation, clicking, nighttime and daytime clenching/gnashing, uncomfortable/non-habitual bite, morning rigidity, and tinnitus. The sociodemographic aspects assessed were age, sex, schooling level, marital status, income, and stages 1 to 3 of the disease. The chi-squared odds ratio was used with a 95% confidence interval and significance level at p < 0.05. Results: an association was verified between nighttime clenching/gnashing and income (p = 0.006); tinnitus and income range from ½ to 3 (p = 0.003) and from 4 to 10 minimum wages (p = 0.004); and between tinnitus and stage 1 (p = 0.02). Conclusion: this study verified that the predictors associated with temporomandibular disorder in people with Parkinson’s disease were pain, clicking, crepitation, uncomfortable/non-habitual bite, and morning rigidity. It was verified that income and stage 1 of the disease had an association with nighttime clenching/gnashing and tinnitus.


PLoS ONE ◽  
2019 ◽  
Vol 14 (6) ◽  
pp. e0217763
Author(s):  
Ya-Yi Chen ◽  
Hueng-Chuen Fan ◽  
Min-Che Tung ◽  
Yu-Kang Chang

Author(s):  
M. C. Verhoeff ◽  
M. Koutris ◽  
M. K. A. van Selms ◽  
A. N. Brandwijk ◽  
M. S. Heres ◽  
...  

Abstract Objectives It is not clear whether dopaminergic medication influences bruxism behaviour in patients with Parkinson’s disease (PD). Therefore, the aims are to investigate (i) the prevalence of possible (i.e., self-reported) bruxism (sleep and awake) in PD patients, and (ii) whether the use of dopaminergic medication and other factors (viz., demographic characteristics, PD-related factors, and possible consequences of bruxism) are associated with possible bruxism (sleep or awake). Materials and methods This study concerns a secondary analysis of an earlier published study. Three hundred ninety-five PD patients (67.9 ± 8.6 years of age; 58.7% males) were included. The levodopa equivalent daily dosage (LEDD) was used as a measure of the dopaminergic medication level. Subsequently, a logistic regression analysis was performed for the dependent variables ‘awake bruxism’ and ‘sleep bruxism’, with the following predictors: gender, age, LEDD, time since PD diagnosis, temporomandibular disorder (TMD) pain, jaw locks, and tooth wear. Results The prevalence of possible awake and sleep bruxism was 46.0% and 24.3%, respectively. Awake bruxism was associated with sleep bruxism (OR = 8.52; 95% CI 3.56–20.40), TMD pain (OR = 4.51; 95% CI 2.31–8.79), and tooth wear (OR = 1.87; 95% CI 1.02–3.43). Sleep bruxism was associated with tooth wear (OR = 12.49; 95% CI 4.97–31.38) and awake bruxism (OR = 9.48; 95% CI 4.24–21.19). Dopaminergic medication dose was not associated with awake bruxism (OR = 1.0; 95% CI 0.99–1.00) or sleep bruxism (OR = 1.0; 95% CI 0.99–1.00). Conclusion Bruxism is a common condition in PD patients, but is not associated with the dopaminergic medication dose. Clinical relevance (Oral) health care providers should be alerted about the possibility of sleep and awake bruxism activity in PD patients, along with this activity’s possible negative health outcomes (viz., TMD pain, tooth wear).


Author(s):  
Raíssa Barreto Tavares ◽  
Jonatas Silva de Oliveira ◽  
Patrícia Fernanda Faccio ◽  
Maria das Graças Wanderley de Sales Coriolano ◽  
Nadja Maria Jorge Asano ◽  
...  

Revista CEFAC ◽  
2019 ◽  
Vol 21 (3) ◽  
Author(s):  
Renato Mariano da Silva ◽  
Vilma Lucia dos Santos ◽  
Taysa Vannoska de Almeida Silva ◽  
Carla Cabral dos Santos Accioly Lins

ABSTRACT Objective: to evaluate the prevalence of temporomandibular joint disorder in people with Parkinson’s disease in a public university hospital, and relate it to sociodemographic factors, general health and oral health self-report, and phase and time of illness. Methods: the Research Diagnostic Criteria for Temporomandibular Disorders were used. The sample was classified according to the diagnosis of temporomandibular disorder and associated with the variables. The odds ratio of Chi-square was applied with a 95% confidence interval and a level of significance set at p<0.05. Results: 110 people presented with Parkinson's disease were assessed. The prevalence of temporomandibular disorder was 35%, being more frequent among males (58%), in elderly people (53%), in phase 2 of the disease (61%), click (37%) being the predominant clinical indication. Of the variables analyzed, only gender and self-perception of oral health showed to be associated with temporomandibular disorders. Conclusion: the presence of temporomandibular disorder has been observed in people with Parkinson's disease, and the fact of being male and reporting moderate oral health seen as associated factors.


2015 ◽  
Vol 27 (3) ◽  
pp. 887-891 ◽  
Author(s):  
Paula Fernanda da Costa Silva ◽  
Daniela Aparecida Biasotto-Gonzalez ◽  
Lara Jansiski Motta ◽  
Soraia Micaela Silva ◽  
Raquel Agnelli Mesquita Ferrari ◽  
...  

Revista CEFAC ◽  
2021 ◽  
Vol 23 (6) ◽  
Author(s):  
Taysa Vannoska de Almeida Silva ◽  
Amanda do Vale Sobral ◽  
Hilton Justino da Silva ◽  
Maria das Graças Wanderley de Sales Coriolano ◽  
Carla Cabral dos Santos Accioly Lins

ABSTRACT Purpose: to assess the bite force in people with Parkinson’s disease and correlate it with age, sex, stage and time of the disease, dentures use, presence of temporomandibular disorder, side of symptom onset, and masticatory preference. Methods: the Research Diagnostic Criteria for Temporomandibular Disorders and the Hoehn & Yahr Parkinson’s disease scale were used, and the participants’ oral cavity was clinically examined. Then, the bite force was measured with an analog dynamometer, whose bar was adapted for mouth grip. The bite force results and their correlation with the variables were analyzed with the independent t-test (p<0.05). Results: the sample comprised 42 parkinsonians at a mean age of 64 years, 67% of whom were males. No difference was observed in the correlation with age, temporomandibular disorder, stage and time of Parkinson's disease; or between the sides, symptom onset and masticatory preference. However, there was a significant association between the sexes (males and females) for both sides (right - p=0.002; left - p=0.04) and denture use for bite force on the right side (p=0.03). Conclusion: being a female and using dentures are factors associated with decreased bite force in people with Parkinson’s disease.


2021 ◽  
Vol 11 (6) ◽  
pp. 747
Author(s):  
Hyo-Geun Choi ◽  
Joo-Heung Yoon ◽  
Tae-Hwan Chung ◽  
Chanyang Min ◽  
Dae-Myoung Yoo ◽  
...  

This study performed two different analyses using a large set of population data from the Korean National Health Insurance Service Health Screening Cohort to evaluate the interactional association between temporomandibular disorder (TMD) and Parkinson’s disease (PD). Two nested case–control population-based studies were conducted on 514,866 participants. In Study I, 4455 participants with TMD were matched with 17,820 control participants, with a ratio of 1:4. In Study II, 6076 participants with PD were matched with 24,304 control participants, with a ratio of 1:4. Obesity, smoking, alcohol consumption, systolic, diastolic blood pressure, fasting blood glucose level, and total cholesterol were adjusted. The adjusted odds ratio (OR) for TMD was 1.43 (95% confidence interval (CI) = 1.02–2.00) in PD patients compared to non-PD patients in Study I (p < 0.001). The adjusted OR for PD was 1.56 (95% CI = 1.13–2.15) in TMD patients compared to non-TMD patients in Study II (p = 0.007). This study demonstrated that patients with TMD have a significantly higher risk of developing PD and, conversely, those with PD have a significantly higher risk of developing TMD.


Sign in / Sign up

Export Citation Format

Share Document